lobbying_activities: 1884824

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1884824	f94a2f30-034b-442a-b17d-c8ba94dce0e1	Q3	RAMPY NORTHRUP LLC	401103289	AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)	2016	third_quarter	MED	Implementation of P.L.113-93, Protecting Access to Medicare Act of 2014 (changes to reimbursement for clinical laboratory services). Proposals concerning the Stark Law's in-office ancillary services exception. Policies impacting Medicare reimbursement for clinical laboratory services. FDA regulation of clinical laboratory services. H.R.6, 21st Century Cures Act.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2016-10-19T08:57:37.317000-04:00